Jpmorgan Chase & CO Repare Therapeutics Inc. Transaction History
Jpmorgan Chase & CO
- $1.22 Trillion
- Q3 2024
A detailed history of Jpmorgan Chase & CO transactions in Repare Therapeutics Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 4 shares of RPTX stock, worth $11. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4
Previous 4
-0.0%
Holding current value
$11
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding RPTX
# of Institutions
62Shares Held
35.4MCall Options Held
50KPut Options Held
300-
Bvf Inc San Francisco, CA10.3MShares$29 Million1.13% of portfolio
-
Blue Owl Capital Holdings LP New York, NY3.37MShares$9.48 Million3.82% of portfolio
-
Orbimed Advisors LLC San Diego, CA3.32MShares$9.34 Million0.27% of portfolio
-
Chi Advisors LLC New York, NY2.97MShares$8.34 Million17.66% of portfolio
-
Versant Venture Management, LLC San Francisco, CA2.65MShares$7.44 Million23.86% of portfolio
About Repare Therapeutics Inc.
- Ticker RPTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,937,800
- Market Cap $118M
- Description
- Repare Therapeutics Inc., a clinical-stage precision oncology company, discovers and develops therapeutics by using its synthetic lethality approach in Canada and the United States. The company uses its SNIPRx, a proprietary, genome-wide, and CRISPR-enabled platform to systematically discover and develop highly targeted cancer therapies that foc...